Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

The Word Brain 2015Free PDF | Print | Web
A short guide to fast language learning

Free Abstracts

  Rheumatoid Arthritis

  Free Subscription


Articles published in Arthritis Rheum

Retrieve available abstracts of 324 articles:
HTML format
Text format



Single Articles


    January 2014
  1. MIKULS TR, Payne JB, Yu F, Thiele GM, et al
    Periodontitis and Porphyromonas gingivalis in Patients with Rheumatoid Arthritis.
    Arthritis Rheum. 2014 Jan 8. doi: 10.1002/art.38348.
    PubMed     Text format     Abstract available


  2. LEIPE J, Schramm MA, Prots I, Schulze-Koops H, et al
    Increased Th17 cell frequency and poor clinical outcome in rheumatoid arthritis are associated with a genetic variant in the IL-4R gene, rs1805010.
    Arthritis Rheum. 2014 Jan 8. doi: 10.1002/art.38343.
    PubMed     Text format     Abstract available


  3. MORET FM, Hack CE, van der Wurff-Jacobs KM, Radstake TR, et al
    Thymic stromal lymphopoietin (TSLP): a novel proinflammatory mediator in rheumatoid arthritis that potently activates CD1c myeloid dendritic cells to attract and stimulate T cells.
    Arthritis Rheum. 2014 Jan 8. doi: 10.1002/art.38338.
    PubMed     Text format     Abstract available


  4. JIANG L, Yin J, Ye L, Yang J, et al
    Novel risk loci for rheumatoid arthritis in han chinese and congruence with risk variants in europeans.
    Arthritis Rheum. 2014 Jan 8. doi: 10.1002/art.38353.
    PubMed     Text format     Abstract available


  5. PARK YJ, Kim JY, Park J, Choi JJ, et al
    Bone Erosion is Associated with Reduction of Circulating Endothelial Progenitor Cells and Endothelial Dysfunction in Rheumatoid Arthritis.
    Arthritis Rheum. 2014 Jan 8. doi: 10.1002/art.38352.
    PubMed     Text format     Abstract available


    December 2013
  6. VAN DE STADT LA, de Vrieze H, Derksen NI, Brouwer M, et al
    Antibodies to IgG4 hinge can be found in Rheumatoid Arthritis patients during all stages of disease and may exacerbate chronic antibody-mediated inflammation.
    Arthritis Rheum. 2013 Dec 24. doi: 10.1002/art.38335.
    PubMed     Text format     Abstract available


  7. CHU SY, Yeter K, Kotha R, Pong E, et al
    Suppression of rheumatoid arthritis B cells by XmAb5871, an anti-CD19 antibody that coengages B cell antigen receptor and FcgammaRIIb inhibitory receptor.
    Arthritis Rheum. 2013 Dec 24. doi: 10.1002/art.38334.
    PubMed     Text format     Abstract available


  8. KUNG TN, Dennis J, Ma Y, Xie G, et al
    RFC-1 80G>A is a genetic determinant of methotrexate efficacy in Rheumatoid Arthritis: A HuGE review and meta-analysis of observational studies.
    Arthritis Rheum. 2013 Dec 24. doi: 10.1002/art.38331.
    PubMed     Text format     Abstract available


  9. SOLOMON DH, Bitton A, Katz JN, Radner H, et al
    Treat to target in rheumatoid arthritis: Fact, fiction or hypothesis?
    Arthritis Rheum. 2013 Dec 24. doi: 10.1002/art.38323.
    PubMed     Text format    


  10. CONWAY R, Low C, Coughlan RJ, O'Donnell MJ, et al
    Methotrexate and lung disease in rheumatoid arthritis - A meta-analysis of randomized controlled trials.
    Arthritis Rheum. 2013 Dec 24. doi: 10.1002/art.38322.
    PubMed     Text format     Abstract available


  11. KULLER LH, Mackey RH, Walitt BT, Deane KD, et al
    Determinants of mortality among postmenopausal women who report rheumatoid arthritis in the Women's Health Initiative.
    Arthritis Rheum. 2013 Dec 23. doi: 10.1002/art.38268.
    PubMed     Text format     Abstract available


  12. MA KK, Nelson JL, Guthrie KA, Dugowson CE, et al
    Adverse pregnancy outcomes and risk of subsequent rheumatoid arthritis.
    Arthritis Rheum. 2013 Dec 18. doi: 10.1002/art.38247.
    PubMed     Text format     Abstract available


  13. SINGH JA
    Arthroplasty outcomes are improving, but why isn't my patient with rheumatoid arthritis doing as well?
    Arthritis Rheum. 2013 Dec 18. doi: 10.1002/art.38236.
    PubMed     Text format    


  14. DU Y, Cui Y, Liu X, Hu F, et al
    The functional but not nonfunctional LILRA3 contributes to sex bias in susceptibility and severity of ACPA-positive rheumatoid arthritis.
    Arthritis Rheum. 2013 Dec 10. doi: 10.1002/art.38308.
    PubMed     Text format     Abstract available


  15. WIDDIFIELD J, Paterson JM, Bernatsky S, Tu K, et al
    The epidemiology of rheumatoid arthritis (RA) in Ontario, Canada.
    Arthritis Rheum. 2013 Dec 10. doi: 10.1002/art.38306.
    PubMed     Text format     Abstract available


  16. BAKER JF, Conaghan PG, Smolen JS, Aletaha D, et al
    Development and validation of modified disease activity scores in rheumatoid arthritis: Superior correlation with MRI synovitis and X-ray progression.
    Arthritis Rheum. 2013 Dec 10. doi: 10.1002/art.38304.
    PubMed     Text format     Abstract available


  17. LEE HS, Woo SJ, Koh HW, Ka SO, et al
    Regulation of apoptosis and inflammatory responses by IGFBP-3 in fibroblast-like synoviocytes and experimental animal models of rheumatoid arthritis.
    Arthritis Rheum. 2013 Dec 10. doi: 10.1002/art.38303.
    PubMed     Text format     Abstract available


  18. KOBAYASHI S, Murata K, Shibuya H, Morita M, et al
    A distinct human CD4+ T cell subset that secretes CXCL13 in rheumatoid synovium.
    Arthritis Rheum. 2013;65:3063-72.
    PubMed     Text format     Abstract available


  19. TOBON GJ, Saraux A, Gottenberg JE, Quartuccio L, et al
    Role of Fms-like tyrosine kinase 3 ligand as a potential biologic marker of lymphoma in primary Sjogren's syndrome.
    Arthritis Rheum. 2013;65:3218-27.
    PubMed     Text format     Abstract available


  20. LAUVSNES MB, Maroni SS, Appenzeller S, Beyer MK, et al
    Memory dysfunction in primary Sjogren's syndrome is associated with anti-NR2 antibodies.
    Arthritis Rheum. 2013;65:3209-17.
    PubMed     Text format     Abstract available


  21. YIN H, Cabrera-Perez J, Lai Z, Michael D, et al
    Association of bone morphogenetic protein 6 with exocrine gland dysfunction in patients with Sjogren's syndrome and in mice.
    Arthritis Rheum. 2013;65:3228-38.
    PubMed     Text format     Abstract available


    November 2013
  22. RAVI B , Croxford R, Hollands S, Paterson MJ, et al
    Patients with rheumatoid arthritis are at increased risk for complications following total joint arthroplasty.
    Arthritis Rheum. 2013 Nov 19. doi: 10.1002/art.38231.
    PubMed     Text format     Abstract available


  23. IKEDA K , Seto Y, Narita A, Kawakami A, et al
    Ultrasound assessment of synovial pathologies in rheumatoid arthritis using comprehensive multi-plane images of the 2 metacarpophalangeal joint - Identification of the components which are reliable and influential on the global assessment of the whole
    Arthritis Rheum. 2013 Nov 18. doi: 10.1002/art.38280.
    PubMed     Text format     Abstract available


  24. DE HAIR MJ , van de Sande MG, Ramwadhdoebe TH, Hansson M, et al
    Features of the synovium of individuals at risk of developing rheumatoid arthritis: Implications for understanding preclinical rheumatoid arthritis.
    Arthritis Rheum. 2013 Nov 18. doi: 10.1002/art.38273.
    PubMed     Text format     Abstract available


  25. KIM HR , Kim KW, Kim BM, Jung HG, et al
    Reciprocal activation of CD4+T cells and synovial fibroblasts by SDF-1 promotes RANKL expression and osteoclastogenesis in rheumatoid arthritis.
    Arthritis Rheum. 2013 Nov 18. doi: 10.1002/art.38286.
    PubMed     Text format     Abstract available


  26. TOYODA Y , Tabata S, Kishi J, Kuramoto T, et al
    Thymidine phosphorylase regulates the expression of CXCL10 in rheumatoid arthritis fibroblast-like synoviocytes.
    Arthritis Rheum. 2013 Nov 18. doi: 10.1002/art.38263.
    PubMed     Text format     Abstract available


  27. DE STEENWINKEL FD , Hokken-Koelega AC, Hazes JM, Dolhain RJ, et al
    Does medication or disease activity during pregnancy in patients with rheumatoid arthritis (RA), Influence bone density of their 7-year-old offspring?
    Arthritis Rheum. 2013 Nov 18. doi: 10.1002/art.38281.
    PubMed     Text format     Abstract available


  28. DE ROTTE MC , de Jong PH, Pluijm SM, Calasan MB, et al
    Association of low baseline levels of erythrocyte folate with treatment nonresponse at three months in rheumatoid arthritis patients receiving methotrexate.
    Arthritis Rheum. 2013;65:2803-13.
    PubMed     Text format     Abstract available


  29. GOULES AV, Tatouli IP, Moutsopoulos HM, Tzioufas AG, et al
    Clinically significant renal involvement in primary Sjogren's syndrome: clinical presentation and outcome.
    Arthritis Rheum. 2013;65:2945-53.
    PubMed     Text format     Abstract available


  30. BOHM BB, Freund I, Krause K, Kinne RW, et al
    ADAM15 adds to apoptosis resistance of synovial fibroblasts by modulating focal adhesion kinase signaling.
    Arthritis Rheum. 2013;65:2826-34.
    PubMed     Text format     Abstract available


  31. FRISELL T, Holmqvist M, Kallberg H, Klareskog L, et al
    Familial risks and heritability of rheumatoid arthritis: role of rheumatoid factor/anti-citrullinated protein antibody status, number and type of affected relatives, sex, and age.
    Arthritis Rheum. 2013;65:2773-82.
    PubMed     Text format     Abstract available


  32. VAN DER WOUDE D, Grondal G, Huizinga TW
    Family studies in the information age.
    Arthritis Rheum. 2013;65:2762-4.
    PubMed     Text format    


    October 2013
  33. REYNISDOTTIR G , Karimi R, Joshua V, Olsen H, et al
    Structural lung changes and local anti-citrulline immunity are early features of anti citrullinated-proteins antibodies positive rheumatoid arthritis.
    Arthritis Rheum. 2013 Oct 21. doi: 10.1002/art.38201.
    PubMed     Text format     Abstract available


  34. DEL RINCON I , Battafarano DF, Restrepo JF, Erikson JM, et al
    Glucocorticoid dose thresholds associated with all-cause and cardiovascular mortality in rheumatoid arthritis.
    Arthritis Rheum. 2013 Oct 7. doi: 10.1002/art.38210.
    PubMed     Text format     Abstract available


  35. WAGNER U, Schatz A, Baerwald C, Rossol M, et al
    Brief report: deficient thymic output in rheumatoid arthritis despite abundance of prethymic progenitors.
    Arthritis Rheum. 2013;65:2567-72.
    PubMed     Text format     Abstract available


  36. LI J, Yang P, Wu Q, Li H, et al
    Death receptor 5-targeted depletion of interleukin-23-producing macrophages, Th17, and Th1/17 associated with defective tyrosine phosphatase in mice and patients with rheumatoid arthritis.
    Arthritis Rheum. 2013;65:2594-605.
    PubMed     Text format     Abstract available


    September 2013
  37. DUCREUX J , Durez P, Galant C, Toukap AN, et al
    Global molecular effects of tocilizumab therapy in the rheumatoid arthritis synovium.
    Arthritis Rheum. 2013 Sep 24. doi: 10.1002/art.38202.
    PubMed     Text format     Abstract available


  38. AMMITZBOLL CG , Thiel S, Jensenius JC, Ellingsen T, et al
    M-ficolin reflects disease activity and predicts remission in early rheumatoid arthritis.
    Arthritis Rheum. 2013 Sep 10. doi: 10.1002/art.38179.
    PubMed     Text format     Abstract available


  39. KATO M , Ospelt C, Gay RE, Gay S, et al
    Dual role of autophagy in stress-induced cell death in rheumatoid arthritis synovial fibroblasts.
    Arthritis Rheum. 2013 Sep 10. doi: 10.1002/art.38190.
    PubMed     Text format     Abstract available


  40. XU T , Huang C, Li Y, Deng Z, et al
    Fcgamma receptor IIB play a controversial role in Toll-like receptor 2 involved rheumatoid arthritis: Comment on the article by Shahla Abdollahi-Roodsaz et al.
    Arthritis Rheum. 2013 Sep 10. doi: 10.1002/art.38186.
    PubMed     Text format    


  41. MCALLISTER K , Yarwood A, Bowes J, Orozco G, et al
    Meta-analysis identifies BACH2 and RAD51B as rheumatoid arthritis susceptibility loci.
    Arthritis Rheum. 2013 Sep 10. doi: 10.1002/art.38183.
    PubMed     Text format     Abstract available


  42. KOSINSKA MK, Liebisch G, Lochnit G, Wilhelm J, et al
    A lipidomic study of phospholipid classes and species in human synovial fluid.
    Arthritis Rheum. 2013;65:2323-33.
    PubMed     Text format     Abstract available


  43. SCHMIDT EM, Davies M, Mistry P, Green P, et al
    Selective blockade of tumor necrosis factor receptor I inhibits proinflammatory cytokine and chemokine production in human rheumatoid arthritis synovial membrane cell cultures.
    Arthritis Rheum. 2013;65:2262-73.
    PubMed     Text format     Abstract available


    August 2013
  44. LIN J , Huo R, Xiao L, Zhu X, et al
    A novel p53-miR-22-Cyr61 axis in synovial cells regulates inflammation in Rheumatoid Arthritis.
    Arthritis Rheum. 2013 Aug 27. doi: 10.1002/art.38142.
    PubMed     Text format     Abstract available


  45. KRABBEN A , Wilson AG, de Rooy DP, Zhernakova A, et al
    Genetic variants in the IL-4 and IL-4 receptor genes in association with the severity of joint damage in rheumatoid arthritis: a study in seven cohorts.
    Arthritis Rheum. 2013 Aug 27. doi: 10.1002/art.38141.
    PubMed     Text format     Abstract available


  46. VAN DE SANDE MG , de Launay D, de Hair MJ, Garcia S, et al
    Local synovial engagement of angiogenic Tie2 is associated with the development of persistent erosive rheumatoid arthritis in early arthritis patients.
    Arthritis Rheum. 2013 Aug 27. doi: 10.1002/art.38128.
    PubMed     Text format     Abstract available


  47. DANILA MI , Reynolds RJ, Tiwari HK, Bridges SL Jr, et al
    Ethnic-specific genetic analyses in rheumatoid arthritis: Incremental gains but valuable contributions to the big picture.
    Arthritis Rheum. 2013 Aug 5. doi: 10.1002/art.38111.
    PubMed     Text format    


  48. NEGI S , Juyal G, Senapati S, Prasad P, et al
    A genome-wide association study reveals ARL15, a novel non-HLA susceptibility gene for Rheumatoid arthritis in north Indians.
    Arthritis Rheum. 2013 Aug 5. doi: 10.1002/art.38110.
    PubMed     Text format     Abstract available


  49. MELET J , Mulleman D, Goupille P, Ribourtout B, et al
    Rituximab-induced T-cell depletion in patients with rheumatoid arthritis: Association with clinical response.
    Arthritis Rheum. 2013 Aug 5. doi: 10.1002/art.38107.
    PubMed     Text format     Abstract available


  50. CHARLES-SCHOEMAN C , Lee YY, Shahbazian A, Gorn AH, et al
    Association of Paraoxonase 1 gene polymorphisms and enzyme activity with carotid plaque in rheumatoid arthritis.
    Arthritis Rheum. 2013 Aug 5. doi: 10.1002/art.38118.
    PubMed     Text format     Abstract available


  51. YOUNG SP , Kapoor SR, Viant MR, Byrne JJ, et al
    The impact of inflammation on metabolomic profiles in patients with arthritis.
    Arthritis Rheum. 2013;65:2015-23.
    PubMed     Text format     Abstract available


  52. DVERGSTEN JA , Mueller RG, Griffin P, Abedin S, et al
    Premature cell senescence and T cell receptor-independent activation of CD8+ T cells in juvenile idiopathic arthritis.
    Arthritis Rheum. 2013;65:2201-10.
    PubMed     Text format     Abstract available


  53. MIYABE Y , Miyabe C, Iwai Y, Takayasu A, et al
    Necessity of lysophosphatidic acid receptor 1 for development of arthritis.
    Arthritis Rheum. 2013;65:2037-47.
    PubMed     Text format     Abstract available


  54. VAN ROON JA , Kruize AA, Radstake TR
    Editorial: interleukin-7 and its receptor: the axis of evil to target in Sjogren's syndrome?
    Arthritis Rheum. 2013;65:1980-4.
    PubMed     Text format    


    July 2013
  55. JONES BA , Riegsecker S, Rahman A, Beamer M, et al
    Role of ADAM17, p38 MAPK, cathepsins, and proteasome pathway in the synthesis and shedding of fractalkine/CX3CL1 in rheumatoid arthritis.
    Arthritis Rheum. 2013 Jul 29. doi: 10.1002/art.38095.
    PubMed     Text format     Abstract available


  56. BLITS M , Jansen G, Assaraf YG, van de Wiel MA, et al
    Methotrexate normalizes upregulated folate pathway genes in rheumatoid arthritis.
    Arthritis Rheum. 2013 Jul 29. doi: 10.1002/art.38094.
    PubMed     Text format     Abstract available


  57. HA YJ , Lee SW, Lee SK, Park YB, et al
    Osteoporotic calcaneal stress fractures mistaken for aggravation of rheumatoid arthritis.
    Arthritis Rheum. 2013 Jul 29. doi: 10.1002/art.38088.
    PubMed     Text format    


  58. PERERA J , Liu X, Zhou Y, Joseph NE, et al
    Insufficient autoantigen presentation and failure of tolerance in a mouse model of rheumatoid arthritis.
    Arthritis Rheum. 2013 Jul 9. doi: 10.1002/art.38085.
    PubMed     Text format     Abstract available


  59. RANGANATH VK , Strand V, Peterfy CG, Ostergaard M, et al
    The utility of magnetic resonance imaging for assessing structural damage in randomized controlled trials in rheumatoid arthritis: Report from the imaging group of the American College of Rheumatology RA clinical trials task force.
    Arthritis Rheum. 2013 Jul 9. doi: 10.1002/art.38083.
    PubMed     Text format    


  60. CROWSON CS , Therneau TM, Davis JM 3rd, Roger VL, et al
    Accelerated aging influences cardiovascular disease risk in rheumatoid arthritis.
    Arthritis Rheum. 2013 Jul 1. doi: 10.1002/art.38071.
    PubMed     Text format     Abstract available


  61. CHEN YM , Chuang HC, Lin WC, Tsai CY, et al
    GLK overexpression in T cells as a novel biomarker in rheumatoid arthritis.
    Arthritis Rheum. 2013 Jul 1. doi: 10.1002/art.38067.
    PubMed     Text format     Abstract available


  62. WILLIS VC , Demoruelle MK, Derber LA, Chartier-Logan CJ, et al
    Sputa autoantibodies in patients with established rheumatoid arthritis and subjects at-risk for future clinically apparent disease.
    Arthritis Rheum. 2013 Jul 1. doi: 10.1002/art.38066.
    PubMed     Text format     Abstract available


  63. TEARE MD , Knevel R, Morgan MD, Kleszcz A, et al
    Allele dose association of the C5orf30 rs26232 variant with joint damage in rheumatoid arthritis.
    Arthritis Rheum. 2013 Jul 1. doi: 10.1002/art.38064.
    PubMed     Text format     Abstract available


  64. ISOZAKI T , Arbab AS, Haas CS, Amin MA, et al
    Evidence that CXCL16 is a potent mediator of angiogenesis and is involved in endothelial progenitor cell chemotaxis : studies in mice with K/BxN serum-induced arthritis.
    Arthritis Rheum. 2013;65:1736-46.
    PubMed     Text format     Abstract available


  65. LEE HS , Ka SO, Lee SM, Lee SI, et al
    Overexpression of sirtuin 6 suppresses inflammatory responses and bone destruction in mice with collagen-induced arthritis.
    Arthritis Rheum. 2013;65:1776-85.
    PubMed     Text format     Abstract available


  66. VITALI C , Carotti M, Salaffi F
    Is it the time to adopt salivary gland ultrasonography as an alternative diagnostic tool for the classification of patients with Sjogren's syndrome? Comment on the article by Cornec et al.
    Arthritis Rheum. 2013;65:1950.
    PubMed     Text format    


  67. CORNEC D , Jousse-Joulin S, Saraux A, Devauchelle-Pensec V, et al
    Reply.
    Arthritis Rheum. 2013;65:1951.
    PubMed     Text format    


  68. NAM EJ , Kang JH, Sung S, Sa KH, et al
    A matrix metalloproteinase 1-cleavable composite peptide derived from transforming growth factor beta-inducible gene h3 potently inhibits collagen-induced arthritis.
    Arthritis Rheum. 2013;65:1753-63.
    PubMed     Text format     Abstract available


  69. OSTERGAARD O , Nielsen CT, Iversen LV, Tanassi JT, et al
    Unique protein signature of circulating microparticles in systemic lupus erythematosus.
    Arthritis Rheum. 2013 Jul 1. doi: 10.1002/art.38065.
    PubMed     Text format     Abstract available


    June 2013
  70. YOUNG KA , Deane KD, Derber LA, Hughes-Austin JM, et al
    Relatives without rheumatoid arthritis show reactivity to anti-citrullinated protein/peptide antibodies which are associated with arthritis-related traits: Studies of the etiology of rheumatoid arthritis.
    Arthritis Rheum. 2013 Jun 10. doi: 10.1002/art.38022.
    PubMed     Text format     Abstract available


  71. SELLAM J , Rouanet S, Hendel-Chavez H, Miceli-Richard C, et al
    CCL19, a B-cell chemokine, is related to the decrease of blood memory B-cells and predicts the clinical response to rituximab in rheumatoid arthritis.
    Arthritis Rheum. 2013 Jun 5. doi: 10.1002/art.38023.
    PubMed     Text format     Abstract available


  72. WAIMANN CA , Marengo MF, de Achaval S, Cox VL, et al
    Electronic monitoring of oral therapies in ethnically diverse and economically disadvantaged patients with rheumatoid arthritis: consequences of low adherence.
    Arthritis Rheum. 2013;65:1421-9.
    PubMed     Text format     Abstract available


  73. KEITH RC , Sokolove J, Edelman BL, Lahey L, et al
    Testosterone is protective in the sexually dimorphic development of arthritis and lung disease in SKG mice.
    Arthritis Rheum. 2013;65:1487-93.
    PubMed     Text format     Abstract available


  74. SIMARD JF , Neovius M, Askling J
    Reply.
    Arthritis Rheum. 2013;65:1671-2.
    PubMed     Text format    


  75. GERARDI MC , De Luca N, Alessandri C, Iannuccelli C, et al
    Frequency of antibodies to mutated citrullinated vimentin in chronic obstructive pulmonary disease: comment on the article by Demoruelle et al.
    Arthritis Rheum. 2013;65:1672-3.
    PubMed     Text format    


    May 2013
  76. DEMORUELLE MK , Parish MC, Derber LA, Kolfenbach JR, et al
    Anti-cyclic citrullinated peptide assays differ in subjects at elevated risk for rheumatoid arthritis and subjects with established disease.
    Arthritis Rheum. 2013 May 17. doi: 10.1002/art.38017.
    PubMed     Text format     Abstract available


  77. GARTNER M , Mandl P, Radner H, Supp G, et al
    Sonographic joint assessment in rheumatoid arthritis: Associations with clinical joint assessment in remission.
    Arthritis Rheum. 2013 May 17. doi: 10.1002/art.38016.
    PubMed     Text format     Abstract available


  78. VAN STEENBERGEN HW , Huizinga TW, van der Helm-van Mil AH
    The preclinical phase of Rheumatoid Arthritis, what is acknowledged and what needs to be assessed?
    Arthritis Rheum. 2013 May 17. doi: 10.1002/art.38013.
    PubMed     Text format    


  79. O'DELL JR , Curtis JR, Mikuls T, Cofield S, et al
    Validation of methotrexate-first strategy in early poor prognosis rheumatoid arthritis: Results from a randomized, double-blind, 2-year trial.
    Arthritis Rheum. 2013 May 17. doi: 10.1002/art.38012.
    PubMed     Text format     Abstract available


  80. KIM SJ , Chen Z, Chamberlain ND, Volin MV, et al
    Angiogenesis in rheumatoid arthritis is directly fostered by TLR5 ligation and indirectly through IL-17 induction.
    Arthritis Rheum. 2013 May 10:NA. doi: 10.1002/art.37992.
    PubMed     Text format     Abstract available


  81. JIN JO , Kawai T, Cha S, Yu Q, et al
    Interleukin-7 enhances Th1 response to promote the development of Sjogren's Syndrome-Like autoimmune exocrinopathy.
    Arthritis Rheum. 2013 May 10. doi: 10.1002/art.38007.
    PubMed     Text format     Abstract available


  82. GLANT TT , Besenyei T, Kadar A, Kurko J, et al
    Differentially expressed epigenome modifiers, including Aurora kinase A and B, in immune cells of rheumatoid arthritis.
    Arthritis Rheum. 2013 May 8:NA. doi: 10.1002/art.37986.
    PubMed     Text format     Abstract available


  83. BEUKELMAN T , Xie F, Baddley JW, Chen L, et al
    Brief report: incidence of selected opportunistic infections among children with juvenile idiopathic arthritis.
    Arthritis Rheum. 2013;65:1384-9.
    PubMed     Text format     Abstract available


  84. HAWKER GA , Badley EM, Borkhoff CM, Croxford R, et al
    Which patients are most likely to benefit from total joint arthroplasty?
    Arthritis Rheum. 2013;65:1243-52.
    PubMed     Text format     Abstract available


  85. CODOLO G , Bossi F, Durigutto P, Bella CD, et al
    Orchestration of inflammation and adaptive immunity in Borrelia burgdorferi-induced arthritis by neutrophil-activating protein A.
    Arthritis Rheum. 2013;65:1232-42.
    PubMed     Text format     Abstract available


  86. SLUKA KA , Rasmussen LA, Edgar MM, O'Donnell JM, et al
    Acid-sensing ion channel 3 deficiency increases inflammation but decreases pain behavior in murine arthritis.
    Arthritis Rheum. 2013;65:1194-202.
    PubMed     Text format     Abstract available


  87. YOSHIOKA Y , Kozawa E, Urakawa H, Arai E, et al
    Suppression of hyaluronan synthesis alleviates inflammatory responses in murine arthritis and in human rheumatoid synovial fibroblasts.
    Arthritis Rheum. 2013;65:1160-70.
    PubMed     Text format     Abstract available


    April 2013
  88. DIXON W
    Data support evidence-based management recommendations for cardiovascular disease in rheumatoid arthritis.
    Arthritis Rheum. 2013 Apr 18. doi: 10.1002/art.37975.
    PubMed     Text format    


  89. STROLLO R , Ponchel F, Malmstrom V, Rizzo P, et al
    Auto-antibodies to post translationally modified type II collagen as potential biomarkers for rheumatoid arthritis.
    Arthritis Rheum. 2013 Apr 10. doi: 10.1002/art.37964.
    PubMed     Text format     Abstract available


  90. MYASOEDOVA E , Davis JM, Crowson CS, Roger VL, et al
    Rheumatoid arthritis is associated with left ventricular concentric remodeling: Results of a population-based cross-sectional study.
    Arthritis Rheum. 2013 Apr 1. doi: 10.1002/art.37949.
    PubMed     Text format     Abstract available


  91. SOKOLOVE J , Sharpe O, Brennan M, Lahey LJ, et al
    Citrullination within the atherosclerotic plaque: A potential target for the anti-citrullinated protein antibody response in rheumatoid arthritis.
    Arthritis Rheum. 2013 Apr 1. doi: 10.1002/art.37961.
    PubMed     Text format     Abstract available


  92. WITT M , Mueller F, Nigg A, Reindl C, et al
    Assessing subclinical synovitis in rheumatoid arthritis.
    Arthritis Rheum. 2013 Apr 1. doi: 10.1002/art.37954.
    PubMed     Text format     Abstract available


  93. LEE A , Qiao Y, Grigoriev G, Chen J, et al
    Tumor necrosis factor alpha induces sustained signaling and a prolonged and unremitting inflammatory response in rheumatoid arthritis synovial fibroblasts.
    Arthritis Rheum. 2013;65:928-38.
    PubMed     Text format     Abstract available


  94. MEI HE , Dorner T
    B cells identified according to their expression of CD19 and surface Ig are depleted from peripheral blood by rituximab in patients with rheumatoid arthritis: comment on the article by Jones et al.
    Arthritis Rheum. 2013;65:1132.
    PubMed     Text format    


  95. ST CLAIR EW , Levesque MC, Prak ET, Vivino FB, et al
    Rituximab therapy for primary Sjogren's syndrome: an open-label clinical trial and mechanistic analysis.
    Arthritis Rheum. 2013;65:1097-106.
    PubMed     Text format     Abstract available


  96. BAY-JENSEN AC , Karsdal MA, Vassiliadis E, Wichuk S, et al
    Circulating citrullinated vimentin fragments reflect disease burden in ankylosing spondylitis and have prognostic capacity for radiographic progression.
    Arthritis Rheum. 2013;65:972-80.
    PubMed     Text format     Abstract available


  97. CANTAERT T , Teitsma C, Tak PP, Baeten D, et al
    Presence and role of anti-citrullinated protein antibodies in experimental arthritis models.
    Arthritis Rheum. 2013;65:939-48.
    PubMed     Text format     Abstract available


  98. SAADOUN D , Terrier B, Bannock J, Vazquez T, et al
    Expansion of autoreactive unresponsive CD21-/low B cells in Sjogren's syndrome-associated lymphoproliferation.
    Arthritis Rheum. 2013;65:1085-96.
    PubMed     Text format     Abstract available


    March 2013
  99. KNEVEL R , de Rooy DP, Zhernakova A, Grondal G, et al
    Association of variants in IL2RA with progression of joint destruction in Rheumatoid Arthritis.
    Arthritis Rheum. 2013 Mar 25. doi: 10.1002/art.37938.
    PubMed     Text format     Abstract available


  100. MOULIS G , Sommet A, Lapeyre-Mestre M
    Commentary on the article "Mortality rates in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors. Drug-specific comparisons in the Swedish Biologics Register"
    Arthritis Rheum. 2013 Mar 18. doi: 10.1002/art.37931.
    PubMed     Text format    


  101. YAZICI H , Tascilar K, Yazici Y
    Neoplasms as the leading cause of mortality among TNF alpha inhibitor users with rheumatoid arthritis? Comment on the article by Simard et al.
    Arthritis Rheum. 2013 Mar 18. doi: 10.1002/art.37930.
    PubMed     Text format    


  102. ROSSOL M , Schubert K, Meusch U, Schulz A, et al
    TNFR1 expression of CD4+ T cells in rheumatoid arthritis enables them to follow TNF gradients into the rheumatoid synovium.
    Arthritis Rheum. 2013 Mar 12. doi: 10.1002/art.37927.
    PubMed     Text format     Abstract available


  103. HERRAEZ DL , Martinez-Bueno M, Riba L, de la Torre IG, et al
    Rheumatoid arthritis in Latin Americans enriched for Amerindian ancestry is associated with loci in chromosomes 1, 12,13, and HLA class II region.
    Arthritis Rheum. 2013 Mar 4. doi: 10.1002/art.37923.
    PubMed     Text format     Abstract available


  104. KAPOOR SR , Filer A, Fitzpatrick MA, Fisher BA, et al
    Metabolic profiling predicts response to anti-TNFalpha therapy in patients with rheumatoid arthritis.
    Arthritis Rheum. 2013 Mar 4. doi: 10.1002/art.37921.
    PubMed     Text format     Abstract available


  105. NAVARRO-MILLAN I , Charles-Schoeman C, Yang S, Bathon JM, et al
    Changes in lipoproteins associated with treatment with methotrexate or combination therapy in early rheumatoid arthritis: Results from the TEAR trial.
    Arthritis Rheum. 2013 Mar 4. doi: 10.1002/art.37916.
    PubMed     Text format     Abstract available


  106. KNEVEL R , Krabben A, Wilson AG, Brouwer E, et al
    A genetic variant in granzyme B is associated with progression of joint destruction in rheumatoid arthritis.
    Arthritis Rheum. 2013;65:582-9.
    PubMed     Text format     Abstract available


  107. WALTER GJ , Evans HG, Menon B, Gullick NJ, et al
    Interaction with activated monocytes enhances cytokine expression and suppressive activity of human CD4+CD45ro+CD25+CD127(low) regulatory T cells.
    Arthritis Rheum. 2013;65:627-38.
    PubMed     Text format     Abstract available


  108. CROXFORD AM , Whittingham S, McNaughton D, Nandakumar KS, et al
    Type II collagen-specific antibodies induce cartilage damage in mice independent of inflammation.
    Arthritis Rheum. 2013;65:650-9.
    PubMed     Text format     Abstract available


    February 2013
  109. PRAHALAD S , Conneely KN, Jiang Y, Sudman M, et al
    Susceptibility to childhood onset rheumatoid arthritis: Investigation of a weighted genetic risk score that integrates cumulative effects of variants at five genetic loci.
    Arthritis Rheum. 2013 Feb 28. doi: 10.1002/art.37913.
    PubMed     Text format     Abstract available


  110. BARRA L , Scinocca M, Saunders S, Bhayana R, et al
    Anti-citrullinated protein antibodies (ACPA) in unaffected first degree relatives of rheumatoid arthritis patients.
    Arthritis Rheum. 2013 Feb 28. doi: 10.1002/art.37911.
    PubMed     Text format     Abstract available


  111. NOZAWA K , Fujishiro M, Kawasaki M, Yamaguchi A, et al
    Inhibition of connective tissue growth factor ameliorates rheumatoid arthritis in a murine model.
    Arthritis Rheum. 2013 Feb 22. doi: 10.1002/art.37902.
    PubMed     Text format     Abstract available


  112. DEMORUELLE MK , Deane KD
    Reply to Geradi and colleagues regarding RA-related autoantibodies and lung disease.
    Arthritis Rheum. 2013 Feb 22. doi: 10.1002/art.37904.
    PubMed     Text format    


  113. PANDA AK , Das BK
    Rheumatoid arthritis patients are free of filarial infection in filarial endemic area.
    Arthritis Rheum. 2013 Feb 11. doi: 10.1002/art.37883.
    PubMed     Text format    


  114. HARLOW L , Rosas IO, Gochuico BR, Mikuls TR, et al
    Identification of citrullinated heat shock protein 90 isoforms as novel autoantigens in rheumatoid arthritis-associated interstitial lung disease.
    Arthritis Rheum. 2013 Feb 11. doi: 10.1002/art.37881.
    PubMed     Text format     Abstract available


  115. DEANE KD , Nicolls MR
    Developing better biomarkers for connective tissue disease-associated interstitial lung disease: Citrullinated HSP-90 autoantibodies in rheumatoid arthritis.
    Arthritis Rheum. 2013 Feb 11. doi: 10.1002/art.37878.
    PubMed     Text format    


  116. CARLSEN AL , Schetter AJ, Nielsen CT, Lood C, et al
    Circulating microRNA expression profiles associated with systemic lupus erythematosus.
    Arthritis Rheum. 2013 Feb 11. doi: 10.1002/art.37890.
    PubMed     Text format     Abstract available


  117. VAN DER WOUDE D , Scherer HU, Huizinga TW, Toes RE, et al
    Pathogenic relevance of anti-citrullinated vimentin antibodies: comment on the article by Montes et al.
    Arthritis Rheum. 2013;65:541-2.
    PubMed     Text format    


  118. MONTES A , Perez-Pampin E, Calaza M, Gomez-Reino JJ, et al
    Reply: Pathogenic relevance of anti-citrullinated vimentin antibodies: comment on the article by Montes et al.
    Arthritis Rheum. 2013;65:542.
    PubMed     Text format    


  119. LANDEWE RB
    Methotrexate saves lives: a pearl of observational research.
    Arthritis Rheum. 2013;65:307-9.
    PubMed     Text format    


    January 2013
  120. GENOVESE MC , Bojin S, Biagini I, Mociran E, et al
    Tabalumab in patients with rheumatoid arthritis with an inadequate response to methotrexate and naive to biologic therapy.
    Arthritis Rheum. 2013 Jan 28. doi: 10.1002/art.37820.
    PubMed     Text format     Abstract available


  121. VAN DER HEIJDE D , Tanaka Y, Fleischmann R, Keystone E, et al
    Tofacitinib (CP-690,550) in patients with rheumatoid arthritis on methotrexate: 12-Month data from a 24-month Phase 3 randomized radiographic study.
    Arthritis Rheum. 2013 Jan 24. doi: 10.1002/art.37816.
    PubMed     Text format     Abstract available


  122. STANFORD SM , Maestre MF, Campbell AM, Bartok B, et al
    PTPome profile of rheumatoid arthritis fibroblast-like synoviocytes: a novel role for SHP-2 as a modulator of invasion and survival.
    Arthritis Rheum. 2013 Jan 17. doi: 10.1002/art.37872.
    PubMed     Text format     Abstract available


  123. NAKAGOMI D , Ikeda K, Okubo A, Iwamoto T, et al
    Ultrasound can improve the accuracy of the 2010 ACR/EULAR classification criteria for rheumatoid arthritis to predict methotrexate requirement.
    Arthritis Rheum. 2013 Jan 17. doi: 10.1002/art.37848.
    PubMed     Text format     Abstract available


  124. BRINK M , Hansson M, Mathsson L, Jakobsson PJ, et al
    Multiplex analyses of antibodies against citrullinated peptides in individuals prior to development of rheumatoid arthritis.
    Arthritis Rheum. 2013 Jan 10. doi: 10.1002/art.37835.
    PubMed     Text format     Abstract available


  125. BOOTSMA H , Spijkervet FK, Kroese FG, Vissink A, et al
    Toward new classification criteria for Sjogren's syndrome?
    Arthritis Rheum. 2013;65:21-3.
    PubMed     Text format    


  126. CORNEC D , Jousse-Joulin S, Pers JO, Marhadour T, et al
    Contribution of salivary gland ultrasonography to the diagnosis of Sjogren's syndrome: toward new diagnostic criteria?
    Arthritis Rheum. 2013;65:216-25.
    PubMed     Text format     Abstract available


  127. VAN DEN BRAND B , Waterborg C, van den Berg W, van de Loo F, et al
    Is the serum amyloid A we use really serum amyloid A? Comment on the article by Connolly et al.
    Arthritis Rheum. 2013;65:283-4.
    PubMed     Text format    


  128. MULLAN RH , Connolly M, Veale DJ, Fearon U, et al
    Is the serum amyloid A we use really serum amyloid A? Comment on the article by Connolly et al. Reply.
    Arthritis Rheum. 2013;65:284-5.
    PubMed     Text format    


  129. VAN BEERS JJ , Schwarte CM, Stammen-Vogelzangs J, Oosterink E, et al
    The rheumatoid arthritis synovial fluid citrullinome reveals novel citrullinated epitopes in apolipoprotein E, myeloid nuclear differentiation antigen, and beta-actin.
    Arthritis Rheum. 2013;65:69-80.
    PubMed     Text format     Abstract available


  130. LI J , Ju Y, Bouta EM, Xing L, et al
    Efficacy of B cell depletion therapy for murine joint arthritis flare is associated with increased lymphatic flow.
    Arthritis Rheum. 2013;65:130-8.
    PubMed     Text format     Abstract available


  131. YEREMENKO N , Noordenbos T, Cantaert T, van Tok M, et al
    Disease-specific and inflammation-independent stromal alterations in spondylarthritis synovitis.
    Arthritis Rheum. 2013;65:174-85.
    PubMed     Text format     Abstract available


    December 2012
  132. BINDER NB , Puchner A, Niederreiter B, Hayer S, et al
    TNF inhibiting therapy preferentially targets bone destruction but not synovial inflammation in a TNF driven model of rheumatoid arthritis.
    Arthritis Rheum. 2012 Dec 28. doi: 10.1002/art.37797.
    PubMed     Text format     Abstract available


  133. TRENKMANN M , Brock M, Gay RE, Michel BA, et al
    The TNFalpha-induced miR-18a activates rheumatoid arthritis synovial fibroblasts through a feedback loop in NF-kappaB signaling.
    Arthritis Rheum. 2012 Dec 28. doi: 10.1002/art.37834.
    PubMed     Text format     Abstract available


  134. PARK JS , Lim MA, Cho ML, Ryu JG, et al
    p53 controls autoimmune arthritis via the STAT3/STAT5-mediated regulation of the Th17-Treg balance.
    Arthritis Rheum. 2012 Dec 28. doi: 10.1002/art.37841.
    PubMed     Text format     Abstract available


  135. PRAKKEN B , Wehrens E, van Wijk F
    Quality or Quantity? Unraveling the role of regulatory T cells in rheumatoid arthritis.
    Arthritis Rheum. 2012 Dec 21. doi: 10.1002/art.37831.
    PubMed     Text format    


  136. SHI J , van de Stadt LA, Levarht EW, Huizinga TW, et al
    Anti Carbamylated Protein Antibodies (anti-CarP) are present in arthralgia patients and predict the development of rheumatoid arthritis.
    Arthritis Rheum. 2012 Dec 21. doi: 10.1002/art.37830.
    PubMed     Text format     Abstract available


  137. RECH J , Hess A, Finzel S, Kreitz S, et al
    Brain functional magnetic resonance activity is associated with response to tumor necrosis factor inhibition in rheumatoid arthritis.
    Arthritis Rheum. 2012 Dec 13. doi: 10.1002/art.37761.
    PubMed     Text format     Abstract available


  138. KOK SH , Lin LD, Hou KL, Hong CY, et al
    Simvastatin inhibits Cyr61 expression in rheumatoid arthritis synovial fibroblasts through the regulation of SIRT1/FoxO3a signaling.
    Arthritis Rheum. 2012 Dec 12. doi: 10.1002/art.37807.
    PubMed     Text format     Abstract available


  139. LING S , Cline EN, Haug TS, Fox DA, et al
    Citrullinated calreticulin potentiates rheumatoid arthritis shared epitope signaling.
    Arthritis Rheum. 2012 Dec 11. doi: 10.1002/art.37814.
    PubMed     Text format     Abstract available


  140. HAN TU , Cho SK, Kim T, Joo YB, et al
    An activity-enhancing variant of IRAK1 and an MECP2-IRAK1 haplotype associating with increased susceptibility to rheumatoid arthritis.
    Arthritis Rheum. 2012 Dec 10. doi: 10.1002/art.37804.
    PubMed     Text format     Abstract available


  141. LIAO KP , Kurreeman F, Li G, Duclos G, et al
    Autoantibodies, autoimmune risk alleles and clinical associations in rheumatoid arthritis cases and non-RA controls in the electronic medical records.
    Arthritis Rheum. 2012 Dec 10. doi: 10.1002/art.37801.
    PubMed     Text format     Abstract available


  142. RAVI B , Escott B, Shah PS, Jenkinson R, et al
    A systematic review and meta-analysis comparing complications following total joint arthroplasty for rheumatoid arthritis versus for osteoarthritis.
    Arthritis Rheum. 2012;64:3839-49.
    PubMed     Text format     Abstract available


  143. LOWIN T , Zhu W, Dettmer-Wilde K, Straub RH, et al
    Cortisol-mediated adhesion of synovial fibroblasts is dependent on the degradation of anandamide and activation of the endocannabinoid system.
    Arthritis Rheum. 2012;64:3867-76.
    PubMed     Text format     Abstract available


  144. KRIECKAERT CL , Jamnitski A, Nurmohamed MT, Kostense PJ, et al
    Comparison of long-term clinical outcome with etanercept treatment and adalimumab treatment of rheumatoid arthritis with respect to immunogenicity.
    Arthritis Rheum. 2012;64:3850-5.
    PubMed     Text format     Abstract available


  145. JOLOBE OM
    Potential interchangeability of erythrocyte hemoglobin content and mean corpuscular hemoglobin for identifying iron deficiency anemia: comment on the article by van Santen et al.
    Arthritis Rheum. 2012;64:4162.
    PubMed     Text format    


  146. STRUGLICS A , Lohmander LS, Last K, Akikusa J, et al
    Aggrecanase cleavage in juvenile idiopathic arthritis patients is minimally detected in the aggrecan interglobular domain but robust at the aggrecan C-terminus.
    Arthritis Rheum. 2012;64:4151-61.
    PubMed     Text format     Abstract available


    November 2012
  147. BONELLI M , Ferner E, Goschl L, Bluml S, et al
    Abatacept (CTLA-4Ig) treatment reduces the migratory capacity of monocytes in patients with rheumatoid arthritis (RA).
    Arthritis Rheum. 2012 Nov 30. doi: 10.1002/art.37787.
    PubMed     Text format     Abstract available


  148. WEINBLATT ME , Schiff M, Valente R, van der Heijde D, et al
    Head-to-head comparison of subcutaneous abatacept versus adalimumab for Rheumatoid Arthritis.
    Arthritis Rheum. 2012 Nov 20. doi: 10.1002/art.37711.
    PubMed     Text format     Abstract available


  149. MD NG , Md GJ
    The effect of triple therapy versus etanercept plus methotrexate in rheumatoid arthritis. A comment to the TEAR study.
    Arthritis Rheum. 2012 Nov 2. doi: 10.1002/art.37757.
    PubMed     Text format    


  150. LARRY M
    Reply to: "The effect of triple therapy versus etanercept plus methotrexate in rheumatoid arthritis. A comment to the TEAR study," by NielsGraudal MD, DMSc and GescheJurgens MD, PhD.
    Arthritis Rheum. 2012 Nov 2. doi: 10.1002/art.37756.
    PubMed     Text format    


  151. ISOZAKI T , Rabquer BJ, Ruth JH, Haines GK 3rd, et al
    A disintegrin and metalloprotease 10 (ADAM10) is overexpressed in rheumatoid arthritis synovial tissue and mediates angiogenesis.
    Arthritis Rheum. 2012 Nov 2. doi: 10.1002/art.37755.
    PubMed     Text format     Abstract available


  152. LEE YC , Lu B, Edwards RR, Wasan AD, et al
    The role of sleep problems in central pain processing in rheumatoid arthritis.
    Arthritis Rheum. 2012 Nov 1. doi: 10.1002/art.37733.
    PubMed     Text format     Abstract available


  153. FORSTER M , Raposo B, Ekman D, Klaczkowska D, et al
    Genetic control of antibody production during collagen-induced arthritis development in heterogeneous stock mice.
    Arthritis Rheum. 2012;64:3594-603.
    PubMed     Text format     Abstract available


  154. MARTINEZ-MARTINEZ MU , Martinez-Lozano J, Abud-Mendoza C
    Hyperglycemia and methylprednisolone: comment on the article by den Uyl et al.
    Arthritis Rheum. 2012;64:3822-3.
    PubMed     Text format    


  155. SIKORA KA , Fall N, Thornton S, Grom AA, et al
    The limited role of interferon-gamma in systemic juvenile idiopathic arthritis cannot be explained by cellular hyporesponsiveness.
    Arthritis Rheum. 2012;64:3799-808.
    PubMed     Text format     Abstract available


  156. JU JH , Heo YJ, Cho ML, Jhun JY, et al
    Modulation of STAT-3 in rheumatoid synovial T cells suppresses Th17 differentiation and increases the proportion of Treg cells.
    Arthritis Rheum. 2012;64:3543-52.
    PubMed     Text format     Abstract available


    October 2012
  157. LEE H , Kashiwakura JI, Matsuda A, Watanabe Y, et al
    Activation of human synovial mast cells from rheumatoid arthritis or osteoarthritis patients in response to aggregated IgG through FcgammaRI and FcgammaRII.
    Arthritis Rheum. 2012 Oct 10. doi: 10.1002/art.37741.
    PubMed     Text format     Abstract available


  158. KORMENDY D , Hoff H, Hoff P, Broker BM, et al
    The impact of the CTLA-4/CD28 axis on the processes of Joint Inflammation in Rheumatoid Arthritis.
    Arthritis Rheum. 2012 Oct 8. doi: 10.1002/art.37714.
    PubMed     Text format     Abstract available


  159. WASKO MC , Dasgupta A, Hubert H, Fries JF, et al
    Propensity-adjusted association of methotrexate with overall survival in rheumatoid arthritis.
    Arthritis Rheum. 2012 Oct 8. doi: 10.1002/art.37723.
    PubMed     Text format     Abstract available


  160. MCGOVERN JL , Nguyen DX, Notley CA, Mauri C, et al
    Th17 cells are restrained by Treg cells via the inhibition of interleukin-6 in patients with rheumatoid arthritis responding to anti-tumor necrosis factor antibody therapy.
    Arthritis Rheum. 2012;64:3129-38.
    PubMed     Text format     Abstract available


  161. LI YT , Chen SY, Wang CR, Liu MF, et al
    Brief report: amelioration of collagen-induced arthritis in mice by lentivirus-mediated silencing of microRNA-223.
    Arthritis Rheum. 2012;64:3240-5.
    PubMed     Text format     Abstract available


  162. DE JONG PH , Weel AE, de Man YA, Huisman AM, et al
    Brief Report: to squeeze or not to squeeze, that is the question! Optimizing the disease activity score in 28 joints by adding the squeeze test of metatarsophalangeal joints in early rheumatoid arthritis.
    Arthritis Rheum. 2012;64:3095-101.
    PubMed     Text format     Abstract available


  163. GORDON RA , Grigoriev G, Lee A, Kalliolias GD, et al
    The interferon signature and STAT1 expression in rheumatoid arthritis synovial fluid macrophages are induced by tumor necrosis factor alpha and counter-regulated by the synovial fluid microenvironment.
    Arthritis Rheum. 2012;64:3119-28.
    PubMed     Text format     Abstract available


  164. COATES LC , Conaghan PG, Emery P, Green MJ, et al
    Sensitivity and specificity of the classification of psoriatic arthritis criteria in early psoriatic arthritis.
    Arthritis Rheum. 2012;64:3150-5.
    PubMed     Text format     Abstract available


  165. VAN DE LOO FA , Veenbergen S, van den Brand B, Bennink MB, et al
    Enhanced suppressor of cytokine signaling 3 in arthritic cartilage dysregulates human chondrocyte function.
    Arthritis Rheum. 2012;64:3313-23.
    PubMed     Text format     Abstract available


  166. PAYELI SK , Kollnberger S, Marroquin Belaunzaran O, Thiel M, et al
    Inhibiting HLA-B27 homodimer-driven immune cell inflammation in spondylarthritis.
    Arthritis Rheum. 2012;64:3139-49.
    PubMed     Text format     Abstract available


    September 2012
  167. FABRIS M , Quartuccio L, Vital E, Pontarini E, et al
    The TTTT BLyS promoter haplotype associates with good response to rituximab therapy in seropositive rheumatoid arthritis resistant to TNF blockers.
    Arthritis Rheum. 2012 Sep 22. doi: 10.1002/art.37707.
    PubMed     Text format     Abstract available


  168. LEONARDI CL
    Serious adverse events-missing in action: comment on the article by Kremer et al.
    Arthritis Rheum. 2012;64:3055-6.
    PubMed     Text format    


  169. MALVIYA A , Rushton SP, Foster HE, Ferris CM, et al
    The relationships between adult juvenile idiopathic arthritis and employment.
    Arthritis Rheum. 2012;64:3016-24.
    PubMed     Text format     Abstract available


  170. VAN TUYL LH , Boers M
    Patient's global assessment of disease activity: what are we measuring?
    Arthritis Rheum. 2012;64:2811-3.
    PubMed     Text format    


  171. LEE SJ , Cho YN, Kim TJ, Park SC, et al
    Natural killer T cell deficiency in active adult-onset Still's Disease: correlation of deficiency of natural killer T cells with dysfunction of natural killer cells.
    Arthritis Rheum. 2012;64:2868-77.
    PubMed     Text format     Abstract available


  172. ERCAN A , Barnes MG, Hazen M, Tory H, et al
    Multiple juvenile idiopathic arthritis subtypes demonstrate proinflammatory IgG glycosylation.
    Arthritis Rheum. 2012;64:3025-33.
    PubMed     Text format     Abstract available


    August 2012
  173. YARILINA A , Xu K, Chan C, Ivashkiv LB, et al
    Regulation of inflammatory responses in tumor necrosis factor - activated and rheumatoid arthritis synovial macrophages by Janus kinase inhibitors.
    Arthritis Rheum. 2012 Aug 31. doi: 10.1002/art.37691.
    PubMed     Text format     Abstract available


  174. MAVRAGANI CP , Schini M, Gravani F, Kaltsas G, et al
    Adrenal autoimmunity in primary Sjogren's syndrome.
    Arthritis Rheum. 2012 Aug 29. doi: 10.1002/art.34679.
    PubMed     Text format     Abstract available


  175. SIMARD JF , Neovius M, Askling J
    Mortality in patients with rheumatoid arthritis treated with TNF inhibitors: drug-specific comparisons in the swedish biologics register.
    Arthritis Rheum. 2012 Aug 8. doi: 10.1002/art.34582.
    PubMed     Text format     Abstract available


  176. BENNETT TD , Fluchel M, Hersh AO, Hayward KN, et al
    Macrophage activation syndrome in children with systemic lupus erythematosus and juvenile idiopathic arthritis.
    Arthritis Rheum. 2012 Aug 8. doi: 10.1002/art.34661.
    PubMed     Text format     Abstract available


  177. BEUKELMAN T , Xie F, Chen L, Baddley JW, et al
    Rates of hospitalized bacterial infection associated with juvenile idiopathic arthritis and its treatment.
    Arthritis Rheum. 2012;64:2773-80.
    PubMed     Text format     Abstract available


  178. STEGAEV V , Sillat T, Porola P, Hanninen A, et al
    Brief report: first identification of H(4) histamine receptor in healthy salivary glands and in focal sialadenitis in Sjogren's syndrome.
    Arthritis Rheum. 2012;64:2663-8.
    PubMed     Text format     Abstract available


  179. OROSA B , Gonzalez A, Mera A, Gomez-Reino JJ, et al
    Lysophosphatidic acid receptor 1 suppression sensitizes rheumatoid fibroblast-like synoviocytes to tumor necrosis factor-induced apoptosis.
    Arthritis Rheum. 2012;64:2460-70.
    PubMed     Text format     Abstract available


  180. THOMPSON SD , Marion MC, Sudman M, Ryan M, et al
    Genome-wide association analysis of juvenile idiopathic arthritis identifies a new susceptibility locus at chromosomal region 3q13.
    Arthritis Rheum. 2012;64:2781-91.
    PubMed     Text format     Abstract available


    July 2012
  181. KIM DJ , Kwok SK, Park SH, Kim HY, et al
    A hole in the elbow in rheumatoid arthritis.
    Arthritis Rheum. 2012 Jul 25. doi: 10.1002/art.34636.
    PubMed     Text format    


  182. NAKAYA HI , Gardner J, Poo YS, Major L, et al
    Gene profiling of chikungunya virus arthritis reveals significant overlap with rheumatoid arthritis.
    Arthritis Rheum. 2012 Jul 25. doi: 10.1002/art.34631.
    PubMed     Text format     Abstract available


  183. TARP S , Bartels EM, Bliddal H, Furst DE, et al
    Effect of nonsteroidal antiinflammatory drugs on C-reactive protein in rheumatoid arthritis: A meta-analysis of randomized controlled trials.
    Arthritis Rheum. 2012 Jul 25. doi: 10.1002/art.34644.
    PubMed     Text format     Abstract available


  184. TAKAHATA M , Maher JR, Juneja SC, Inzana J, et al
    Mechanisms of bone fragility in a glucocorticoid-treated mouse model of rheumatoid arthritis - implications for insufficiency fracture risk.
    Arthritis Rheum. 2012 Jul 25. doi: 10.1002/art.34639.
    PubMed     Text format     Abstract available


  185. STUDENIC P , Radner H, Smolen JS, Aletaha D, et al
    Discrepancies between patients and physicians in the perception of rheumatoid arthritis disease activity.
    Arthritis Rheum. 2012 Jul 18. doi: 10.1002/art.34543.
    PubMed     Text format     Abstract available


  186. KIM SC , Schneeweiss S, Myers JA, Liu J, et al
    Cancer screening rates in patients with rheumatoid arthritis: No different than the general population.
    Arthritis Rheum. 2012 Jul 10. doi: 10.1002/art.34542.
    PubMed     Text format     Abstract available


  187. HUANG QQ , Koessler RE, Birkett R, Dorfleutner A, et al
    Gp96 prpetuates the persistent inflammation of rheumatoid arthritis.
    Arthritis Rheum. 2012 Jul 6. doi: 10.1002/art.34610.
    PubMed     Text format     Abstract available


  188. PROTOGEROU AD , Kitas GD, Sfikakis PP
    Letter on Giles et al.: "Longitudinal predictors of progression of carotid atherosclerosis in rheumatoid arthritis"
    Arthritis Rheum. 2012 Jul 6. doi: 10.1002/art.34612.
    PubMed     Text format    


  189. YAZICI H , Yazici Y
    Are we content that risk of cancer is not appreciably increased after tumor necrosis factor inhibitor use? Comment on the article by Solomon et al.
    Arthritis Rheum. 2012;64:2414.
    PubMed     Text format    


  190. NAIR A , Kanda V, Bush-Joseph C, Verma N, et al
    Synovial fluid from patients with early osteoarthritis modulates fibroblast-like synoviocyte responses to toll-like receptor 4 and toll-like receptor 2 ligands via soluble CD14.
    Arthritis Rheum. 2012;64:2268-77.
    PubMed     Text format     Abstract available


  191. RUUTU M , Thomas G, Steck R, Degli-Esposti MA, et al
    beta-glucan triggers spondylarthritis and Crohn's disease-like ileitis in SKG mice.
    Arthritis Rheum. 2012;64:2211-22.
    PubMed     Text format     Abstract available


  192. AHASAN MM , Hardy R, Jones C, Kaur K, et al
    Inflammatory regulation of glucocorticoid metabolism in mesenchymal stromal cells.
    Arthritis Rheum. 2012;64:2404-13.
    PubMed     Text format     Abstract available


  193. VATTAKUZHI Y , Abraham SM, Freidin A, Clark AR, et al
    Dual-specificity phosphatase 1-null mice exhibit spontaneous osteolytic disease and enhanced inflammatory osteolysis in experimental arthritis.
    Arthritis Rheum. 2012;64:2201-10.
    PubMed     Text format     Abstract available


  194. MIX KS , McMahon K, McMorrow JP, Walkenhorst DE, et al
    Orphan nuclear receptor NR4A2 induces synoviocyte proliferation, invasion, and matrix metalloproteinase 13 transcription.
    Arthritis Rheum. 2012;64:2126-36.
    PubMed     Text format     Abstract available


  195. BRYANT J , Ahern DJ, Brennan FM
    CXCR4 and vascular cell adhesion molecule 1 are key chemokine/adhesion receptors in the migration of cytokine-activated T cells.
    Arthritis Rheum. 2012;64:2137-46.
    PubMed     Text format     Abstract available


  196. HSIA EC , Schluger N, Cush JJ, Chaisson RE, et al
    Interferon-gamma release assay versus tuberculin skin test prior to treatment with golimumab, a human anti-tumor necrosis factor antibody, in patients with rheumatoid arthritis, psoriatic arthritis, or ankylosing spondylitis.
    Arthritis Rheum. 2012;64:2068-77.
    PubMed     Text format     Abstract available


  197. WEIX J , Forger F, Haupl T, Surbek D, et al
    Influence of pregnancy on the adipocytokine and peroxisome proliferator-activated receptor pathways in peripheral blood mononuclear cells from healthy donors and rheumatoid arthritis patients.
    Arthritis Rheum. 2012;64:2095-103.
    PubMed     Text format     Abstract available


  198. CONSOLARO A , Bracciolini G, Ruperto N, Pistorio A, et al
    Remission, minimal disease activity, and acceptable symptom state in juvenile idiopathic arthritis: defining criteria based on the juvenile arthritis disease activity score.
    Arthritis Rheum. 2012;64:2366-74.
    PubMed     Text format     Abstract available


    June 2012
  199. MIKULS TR , Thiele GM, Deane KD, Payne JB, et al
    Porphyromonas gingivalis and disease-related autoantibodies in individuals at increased risk for future rheumatoid arthritis.
    Arthritis Rheum. 2012 Jun 26. doi: 10.1002/art.34595.
    PubMed     Text format     Abstract available


  200. MONTES A , Perez-Pampin E, Calaza M, Gomez-Reino JJ, et al
    Association of anti-citrullinated vimentin and anti-citrullinated alpha-enolase antibodies with subsets of rheumatoid arthritis patients.
    Arthritis Rheum. 2012 Jun 5. doi: 10.1002/art.34569.
    PubMed     Text format     Abstract available


  201. CANTAERT T , Doorenspleet ME, Francosalinas G, Paramarta JE, et al
    Increased numbers of CD5+ B lymphocytes with a regulatory phenotype in spondylarthritis.
    Arthritis Rheum. 2012;64:1859-68.
    PubMed     Text format     Abstract available


  202. KOENDERS MI , Marijnissen RJ, Joosten LA, Abdollahi-Roodsaz S, et al
    T cell lessons from the rheumatoid arthritis synovium SCID mouse model: CD3-rich synovium lacks response to CTLA-4Ig but is successfully treated by interleukin-17 neutralization.
    Arthritis Rheum. 2012;64:1762-70.
    PubMed     Text format     Abstract available


  203. WALLACE CA , Giannini EH, Spalding SJ, Hashkes PJ, et al
    Trial of early aggressive therapy in polyarticular juvenile idiopathic arthritis.
    Arthritis Rheum. 2012;64:2012-21.
    PubMed     Text format     Abstract available


  204. SPURLOCK CF 3RD , Tossberg JT, Fuchs HA, Olsen NJ, et al
    Methotrexate increases expression of cell cycle checkpoint genes via JNK activation.
    Arthritis Rheum. 2012;64:1780-9.
    PubMed     Text format     Abstract available


  205. LOWIN T , Weidler C, Jenei-Lanzl Z, Capellino S, et al
    Relationship between placenta growth factor 1 and vascularization, dehydroepiandrosterone sulfate to dehydroepiandrosterone conversion, or aromatase expression in patients with rheumatoid arthritis and patients with osteoarthritis.
    Arthritis Rheum. 2012;64:1799-808.
    PubMed     Text format     Abstract available


    May 2012
  206. VAN BERGEN J , van Gaalen FA, van Dongen H, Huizinga TW, et al
    Anti-cytomegalovirus seropositivity in rheumatoid arthritis is associated with more severe joint destruction and more frequent joint surgery?
    Arthritis Rheum. 2012 May 17. doi: 10.1002/art.34519.
    PubMed     Text format    


  207. CROWSON CS , Hoganson DD, Fitz-Gibbon PD, Matteson EL, et al
    Development and validation of a risk score for serious infections in patients with rheumatoid arthritis.
    Arthritis Rheum. 2012 May 10. doi: 10.1002/art.34530.
    PubMed     Text format     Abstract available


  208. SCHER JU , Ubeda C, Equinda M, Khanin R, et al
    Periodontal disease and the oral microbiota in new-onset rheumatoid arthritis.
    Arthritis Rheum. 2012 May 10. doi: 10.1002/art.34539.
    PubMed     Text format     Abstract available


  209. KENNA TJ , Davidson SI, Duan R, Bradbury LA, et al
    Enrichment of circulating interleukin-17-secreting interleukin-23 receptor-positive gamma/delta T cells in patients with active ankylosing spondylitis.
    Arthritis Rheum. 2012;64:1420-9.
    PubMed     Text format     Abstract available


  210. WITTOEK R , Cruyssen BV, Verbruggen G
    Predictors of functional impairment and pain in erosive osteoarthritis of the interphalangeal joints: comparison with controlled inflammatory arthritis.
    Arthritis Rheum. 2012;64:1430-6.
    PubMed     Text format     Abstract available


    April 2012
  211. MORELAND LW , O'Dell JR, Paulus HE, Curtis JR, et al
    A randomized comparative effectiveness study of oral triple therapy versus etanercept plus methotrexate in early, aggressive rheumatoid arthritis.
    Arthritis Rheum. 2012 Apr 16. doi: 10.1002/art.34498.
    PubMed     Text format     Abstract available


  212. CHUNG SA , Xie G, Roshandel D, Sherva R, et al
    Meta-analysis in granulomatosis with polyangiitis reveals shared susceptibility loci with rheumatoid arthritis.
    Arthritis Rheum. 2012 Apr 16. doi: 10.1002/art.34496.
    PubMed     Text format     Abstract available


  213. EGELSTON C , Kurko J, Besenyei T, Tryniszewska B, et al
    Suppression of dendritic cell maturation and t cell proliferation by synovial fluid myeloid cells from mice with autoimmune arthritis.
    Arthritis Rheum. 2012 Apr 10. doi: 10.1002/art.34494.
    PubMed     Text format     Abstract available


  214. GUMA M , Hammaker D, Topolewski K, Corr M, et al
    Pro- and anti-inflammatory functions of the p38 pathway in rheumatoid arthritis: Advantages of targeting upstream kinases MKK3 or MKK6.
    Arthritis Rheum. 2012 Apr 5. doi: 10.1002/art.34489.
    PubMed     Text format     Abstract available


  215. MUZ B , Larsen H, Madden L, Kiriakidis S, et al
    Prolyl hydroxylase domain enzyme-2 is the major player in regulating hypoxic responses in rheumatoid arthritis.
    Arthritis Rheum. 2012 Apr 5. doi: 10.1002/art.34479.
    PubMed     Text format     Abstract available


  216. SAMSON M , Audia S, Janikashvili N, Ciudad M, et al
    Inhibition of IL-6 function corrects Th17/Treg imbalance in rheumatoid arthritis patients.
    Arthritis Rheum. 2012 Apr 5. doi: 10.1002/art.34477.
    PubMed     Text format     Abstract available


  217. SPIERA R , Westhovens R
    Provisional classification [corrected] criteria for polymyalgia rheumatica: moving beyond clinical intuition?
    Arthritis Rheum. 2012;64:955-7.
    PubMed     Text format    


  218. DASGUPTA B , Cimmino MA, Kremers HM, Schmidt WA, et al
    2012 Provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative.
    Arthritis Rheum. 2012;64:943-54.
    PubMed     Text format     Abstract available


  219. BEUKELMAN T , Haynes K, Curtis JR, Xie F, et al
    Rates of malignancy associated with juvenile idiopathic arthritis and its treatment.
    Arthritis Rheum. 2012;64:1263-71.
    PubMed     Text format     Abstract available


  220. ONEL KB , Onel K
    Tumor necrosis factor inhibitors and cancer in juvenile idiopathic arthritis: disentangling the web.
    Arthritis Rheum. 2012;64:966-9.
    PubMed     Text format    


  221. RALAINIRINA N , Hentges F, Zimmer J
    Nerve growth factor receptor expression in lymphocytes: comment on the article by Raychaudhuri et al.
    Arthritis Rheum. 2012;64:1295-6.
    PubMed     Text format    


  222. CONNOLLY M , Mullan RH, McCormick J, Matthews C, et al
    Acute-phase serum amyloid A regulates tumor necrosis factor alpha and matrix turnover and predicts disease progression in patients with inflammatory arthritis before and after biologic therapy.
    Arthritis Rheum. 2012;64:1035-45.
    PubMed     Text format     Abstract available


  223. DE BUCOURT M , Scheurig-Munkler C, Feist E, Juran R, et al
    Cyst-like lesions in finger joints detected by conventional radiography: comparison with 320-row multidetector computed tomography.
    Arthritis Rheum. 2012;64:1283-90.
    PubMed     Text format     Abstract available


  224. KUDRYAVTSEVA E , Forde TS, Pucker AD, Adarichev VA, et al
    Wnt signaling genes of murine chromosome 15 are involved in sex-affected pathways of inflammatory arthritis.
    Arthritis Rheum. 2012;64:1057-68.
    PubMed     Text format     Abstract available


    March 2012
  225. SNIR O , Backlund J, Bostrom J, Andersson I, et al
    Multifunctional T cell reactivity to native and glycosylated type-II collagen in rheumatoid arthritis.
    Arthritis Rheum. 2012 Mar 5. doi: 10.1002/art.34459.
    PubMed     Text format     Abstract available


  226. BAJPAI UD , Swainson LA, Mold JE, Graf JD, et al
    A functional variant in FCRL3 is associated with higher FcRL3 expression on T cell subsets and rheumatoid arthritis disease activity.
    Arthritis Rheum. 2012 Mar 5. doi: 10.1002/art.34457.
    PubMed     Text format     Abstract available


  227. PICKENS SR , Chamberlain ND, Volin MV, Pope RM, et al
    Role of the CCL21 and CCR7 pathway in rheumatoid arthritis angiogenesis.
    Arthritis Rheum. 2012 Mar 5. doi: 10.1002/art.34452.
    PubMed     Text format     Abstract available


  228. KRAMER HR , Fontaine KR, Bathon JM, Giles JT, et al
    Muscle density in rheumatoid arthritis: Associations with disease features and functional outcomes.
    Arthritis Rheum. 2012 Mar 5. doi: 10.1002/art.34464.
    PubMed     Text format     Abstract available


    February 2012
  229. EL-GABALAWY HS , Robinson DB, Smolik I, Hart D, et al
    Familial clustering of the serum cytokine profile in the relatives of rheumatoid arthritis patients.
    Arthritis Rheum. 2012 Feb 21. doi: 10.1002/art.34449.
    PubMed     Text format     Abstract available


  230. DEANE K
    Learning about the natural history of rheumatoid arthritis (RA) development through prospective study of subjects at high-risk for RA-related autoimmunity.
    Arthritis Rheum. 2012 Feb 21. doi: 10.1002/art.34445.
    PubMed     Text format    


  231. YAZDANYAR A , Chester Wasko M, Kraemer KL, Ward MM, et al
    Perioperative all-cause mortality and cardiovascular events in patients with rheumatoid arthritis: Comparison with unaffected controls and persons with diabetes mellitus.
    Arthritis Rheum. 2012 Feb 21. doi: 10.1002/art.34428.
    PubMed     Text format     Abstract available


  232. LAKI J , Lundstrom E, Snir O, Ronnelid J, et al
    Very high level of anti-citrullinated peptide antibodies associate with HLA-DRB1*15 non-shared epitope allele in patients with rheumatoid arthritis.
    Arthritis Rheum. 2012 Feb 3. doi: 10.1002/art.34421.
    PubMed     Text format     Abstract available


  233. TAK PP , Mease PJ, Genovese MC, Kremer J, et al
    Safety and efficacy of ocrelizumab in patients with rheumatoid arthritis and an inadequate response to at least one tumor necrosis factor inhibitor: results of a forty-eight-week randomized, double-blind, placebo-controlled, parallel-group phase III t
    Arthritis Rheum. 2012;64:360-70.
    PubMed     Text format     Abstract available


  234. RUPERTO N , Quartier P, Wulffraat N, Woo P, et al
    A phase II, multicenter, open-label study evaluating dosing and preliminary safety and efficacy of canakinumab in systemic juvenile idiopathic arthritis with active systemic features.
    Arthritis Rheum. 2012;64:557-67.
    PubMed     Text format     Abstract available


    January 2012
  235. GAO W , Sweeney C, Connolly M, Kennedy A, et al
    Notch-1 mediates hypoxia-induced angiogenesis in rheumatoid arthritis.
    Arthritis Rheum. 2012 Jan 24. doi: 10.1002/art.34397.
    PubMed     Text format     Abstract available


  236. KHAN NA , Lombeida JI, Singh M, Spencer HJ, et al
    Association of industry funding with the outcome and quality of randomized controlled trials of drug therapy for rheumatoid arthritis.
    Arthritis Rheum. 2012 Jan 24. doi: 10.1002/art.34393.
    PubMed     Text format     Abstract available


  237. ELJAAFARI A , Tartelin ML, Aissaoui H, Chevrel G, et al
    Bone marrow- and synovium-derived mesenchymal cells promote Th-17 cells through caspase-1 activation: Contribution to rheumatoid arthritis chronicity.
    Arthritis Rheum. 2012 Jan 24. doi: 10.1002/art.34391.
    PubMed     Text format     Abstract available


  238. NIELSEN CT , Ostergaard O, Stener L, Iversen LV, et al
    Increased IgG on cell-derived plasma microparticles in systemic lupus erythematosus is associated with autoantibodies and complement activation.
    Arthritis Rheum. 2012 Jan 11. doi: 10.1002/art.34381.
    PubMed     Text format     Abstract available


  239. GRAUDAL N , Jurgens G
    The effect of golimumab (GLM) combined with methotrexate (MTX) on radiographic progression in rheumatoid arthritis (RA).
    Arthritis Rheum. 2012 Jan 9. doi: 10.1002/art.34368.
    PubMed     Text format    


  240. EMERY P , Fleischmann R, van der Heijde D, Keystone EC, et al
    Reply to letter to the editor regarding "The effect of golimumab on radiographic progression in rheumatoid arthritis:
    Arthritis Rheum. 2012 Jan 9. doi: 10.1002/art.34367.
    PubMed     Text format    


  241. WATANABE J , Charles-Schoeman C, Miao Y, Elashoff D, et al
    Proteomic profiling following immunoaffinity capture of HDL: Association of acute phase proteins and complement factors with pro-inflammatory HDL in rheumatoid arthritis.
    Arthritis Rheum. 2012 Jan 9. doi: 10.1002/art.34363.
    PubMed     Text format     Abstract available


  242. CHI PL , Chen YW, Hsiao LD, Chen YL, et al
    HO-1 attenuates IL-1beta-induced cPLA(2) expression via a decrease in NADPH oxidase/ROS/AP-1 activation in human rheumatoid arthritis synovial fibroblasts.
    Arthritis Rheum. 2012 Jan 9. doi: 10.1002/art.34371.
    PubMed     Text format     Abstract available


  243. NOORDENBOS T , Yeremenko N, Gofita I, van de Sande M, et al
    Interleukin-17-positive mast cells contribute to synovial inflammation in spondylarthritis.
    Arthritis Rheum. 2012;64:99-109.
    PubMed     Text format     Abstract available


  244. SOLOMON DH , Mercer E, Kavanaugh A
    Observational studies on the risk of cancer associated with tumor necrosis factor inhibitors in rheumatoid arthritis: a review of their methodologies and results.
    Arthritis Rheum. 2012;64:21-32.
    PubMed     Text format    


  245. STRATTA P , Bozzola C, Quaglia M
    Rheumatoid factor: the end of the term as we know it? Comment on the editorial by Liao et al.
    Arthritis Rheum. 2012;64:320-1.
    PubMed     Text format    


    December 2011
  246. DEMORUELLE MK , Weisman MH, Simonian PL, Lynch DA, et al
    Airways abnormalities and rheumatoid arthritis-related autoantibodies in subjects without arthritis: Early injury or initiating site of autoimmunity?
    Arthritis Rheum. 2011 Dec 19. doi: 10.1002/art.34344.
    PubMed     Text format     Abstract available


  247. PIERER M , Rothe K, Quandt D, Schulz A, et al
    Anti-cytomegalovirus seropositivity in rheumatoid arthritis is associated with more severe joint destruction and more frequent joint surgery.
    Arthritis Rheum. 2011 Dec 19. doi: 10.1002/art.34346.
    PubMed     Text format     Abstract available


  248. WANG CH , Yao H, Chen LN, Jia JF, et al
    CD147 induces angiogenesis through vascular endothelial growth factor and hypoxiainducible transcription factor 1alpha-mediated pathway in rheumatoid arthritis.
    Arthritis Rheum. 2011 Dec 14. doi: 10.1002/art.34341.
    PubMed     Text format     Abstract available


  249. KAROUZAKIS E , Gay RE, Gay S, Neidhart M, et al
    Increased recycling of polyamines is associated with global DNA hypomethylation in rheumatoid arthritis synovial fibroblasts.
    Arthritis Rheum. 2011 Dec 14. doi: 10.1002/art.34340.
    PubMed     Text format     Abstract available


  250. KRAUSZ S , Boumans MJ, Gerlag DM, Lufkin J, et al
    A phase IIa, randomized, double-blind, placebo-controlled trial of apilimod mesylate, an IL-12/IL-23 inhibitor, in patients with rheumatoid arthritis.
    Arthritis Rheum. 2011 Dec 14. doi: 10.1002/art.34339.
    PubMed     Text format     Abstract available


  251. NIEDERER F , Trenkmann M, Ospelt C, Karouzakis E, et al
    Downregulation of microRNA-34a* in rheumatoid arthritis synovial fibroblasts promotes apoptosis resistance.
    Arthritis Rheum. 2011 Dec 12. doi: 10.1002/art.34334.
    PubMed     Text format     Abstract available


  252. YELLIN M , Paliienko I, Balanescu A, Ter-Vartanian S, et al
    A phase II, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of MDX-1100, a fully human anti-CXCL10 monoclonal antibody, in combination with methotrexate in patients with rheumatoid arthritis.
    Arthritis Rheum. 2011 Dec 6. doi: 10.1002/art.34330.
    PubMed     Text format     Abstract available


  253. YOKOTA K , Miyazaki T, Hemmatazad H, Gay RE, et al
    The pattern-recognition receptor NOD1 promotes production of inflammatory mediators in rheumatoid arthritis synovial fibroblasts.
    Arthritis Rheum. 2011 Dec 5. doi: 10.1002/art.34318.
    PubMed     Text format     Abstract available


  254. WECHALEKAR MD , Lester S, Proudman SM, Cleland LG, et al
    Active foot synovitis: Criteria for remission and disease activity underestimate foot involvement in rheumatoid arthritis.
    Arthritis Rheum. 2011 Dec 1. doi: 10.1002/art.33506.
    PubMed     Text format     Abstract available


  255. TEKSTRA J , van Roon J, Groot Kormelink T, Redegeld F, et al
    Immunoglobulin free light chain levels and rituximab response in rheumatoid arthritis: Comment on the article by Sellam et al.
    Arthritis Rheum. 2011;63:4034-5.
    PubMed     Text format    


  256. NOSS EH , Chang SK, Watts GF, Brenner MB, et al
    Modulation of matrix metalloproteinase production by rheumatoid arthritis synovial fibroblasts after cadherin 11 engagement.
    Arthritis Rheum. 2011;63:3768-78.
    PubMed     Text format     Abstract available


  257. NORDKAMP MJ , van Roon JA, Douwes M, de Ruiter T, et al
    Enhanced secretion of leukocyte-associated immunoglobulin-like receptor 2 (LAIR-2) and soluble LAIR-1 in rheumatoid arthritis: LAIR-2 is a more efficient antagonist of the LAIR-1-collagen inhibitory interaction than is soluble LAIR-1.
    Arthritis Rheum. 2011;63:3749-57.
    PubMed     Text format     Abstract available


  258. OSTERGAARD M , Emery P, Conaghan PG, Fleischmann R, et al
    Significant improvement in synovitis, osteitis, and bone erosion following golimumab and methotrexate combination therapy as compared with methotrexate alone: A magnetic resonance imaging study of 318 methotrexate-naive rheumatoid arthritis patients.
    Arthritis Rheum. 2011;63:3712-22.
    PubMed     Text format     Abstract available


  259. SELLAM J , Rouanet S, Hendel-Chavez H, Abbed K, et al
    Blood memory B cells are disturbed and predict the response to rituximab in patients with rheumatoid arthritis.
    Arthritis Rheum. 2011;63:3692-701.
    PubMed     Text format     Abstract available


  260. LAL P , Su Z, Holweg CT, Silverman GJ, et al
    Inflammation and autoantibody markers identify rheumatoid arthritis patients with enhanced clinical benefit following rituximab treatment.
    Arthritis Rheum. 2011;63:3681-91.
    PubMed     Text format     Abstract available


  261. VAN SANTEN S , van Dongen-Lases EC, de Vegt F, Laarakkers CM, et al
    Hepcidin and hemoglobin content parameters in the diagnosis of iron deficiency in rheumatoid arthritis patients with anemia.
    Arthritis Rheum. 2011;63:3672-80.
    PubMed     Text format     Abstract available


  262. DESAI SP , Yazdany J
    Quality measurement and improvement in rheumatology: Rheumatoid arthritis as a case study.
    Arthritis Rheum. 2011;63:3649-60.
    PubMed     Text format    


  263. SATO T , Fujii R, Konomi K, Yagishita N, et al
    Overexpression of SPACIA1/SAAL1, a newly identified gene that is involved in synoviocyte proliferation, accelerates the progression of synovitis in mice and humans.
    Arthritis Rheum. 2011;63:3833-42.
    PubMed     Text format     Abstract available


  264. KAMPERIDIS P , Kamalati T, Ferrari M, Jones M, et al
    Development of a novel recombinant biotherapeutic with applications in targeted therapy of human arthritis.
    Arthritis Rheum. 2011;63:3758-67.
    PubMed     Text format     Abstract available


  265. ALETAHA D , Smolen JS
    Joint damage in rheumatoid arthritis progresses in remission according to the Disease Activity Score in 28 joints and is driven by residual swollen joints.
    Arthritis Rheum. 2011;63:3702-11.
    PubMed     Text format     Abstract available


  266. PARK JK
    Rheumatoid arthritis subgroup with type I interferon signature: comment on the article by Thurlings et al.
    Arthritis Rheum. 2011;63:4033.
    PubMed     Text format    


  267. KAPETANOVIC MC , Roseman C, Jonsson G, Truedsson L, et al
    Antibody response is reduced following vaccination with 7-valent conjugate pneumococcal vaccine in adult methotrexate-treated patients with established arthritis, but not those treated with tumor necrosis factor inhibitors.
    Arthritis Rheum. 2011;63:3723-32.
    PubMed     Text format     Abstract available


    November 2011
  268. MANDL P , Balint P, Brault Y, Backhaus M, et al
    Metrological properties of ultrasound vs. clinical evaluation of synovitis in rheumatoid arthritis: Results of a randomized, multicentre study.
    Arthritis Rheum. 2011 Nov 30. doi: 10.1002/art.33491.
    PubMed     Text format     Abstract available


  269. SUWANNALAI P , van de Stadt LA, Radner H, Steiner G, et al
    Avidity maturation of ACPA in rheumatoid arthritis.
    Arthritis Rheum. 2011 Nov 30. doi: 10.1002/art.33489.
    PubMed     Text format     Abstract available


  270. PERKINS EA , Landis D, Causey Mph ZL, Edberg Y, et al
    Association of single nucleotide polymorphisms (SNPs) in CCR6, TAGAP and TNFAIP3 with rheumatoid arthritis in African Americans.
    Arthritis Rheum. 2011 Nov 29. doi: 10.1002/art.33464.
    PubMed     Text format     Abstract available


  271. VASUDEVAN A , Dicarlo EF, Wright T, Chen D, et al
    Cellular response to prosthetic wear debris differs in rheumatoid versus non-rheumatoid arthritis patients.
    Arthritis Rheum. 2011 Nov 29. doi: 10.1002/art.33459.
    PubMed     Text format     Abstract available


  272. PETERS MA , Wendholt D, Strietholt S, Frank S, et al
    The loss of integrin alpha2beta1 suppresses joint inflammation and cartilage destruction in mouse models of rheumatoid arthritis.
    Arthritis Rheum. 2011 Nov 14. doi: 10.1002/art.33487.
    PubMed     Text format     Abstract available


  273. QUATRE A , Demoux AL, Soussan J, Frances Y, et al
    Salmonella mycotic aneurysm in a patient receiving etanercept for rheumatoid arthritis.
    Arthritis Rheum. 2011 Nov 14. doi: 10.1002/art.33481.
    PubMed     Text format    


  274. ISHIKAWA M , Ito H, Akiyoshi M, Kume N, et al
    Lectin-like oxidized LDL receptor-1 signal is a potent biomarker and therapeutic target for human rheumatoid arthritis.
    Arthritis Rheum. 2011 Nov 10. doi: 10.1002/art.33452.
    PubMed     Text format     Abstract available


  275. RIGBY WF , Wu YL, Zan M, Zhou B, et al
    Increased frequency of complement C4B deficiency in rheumatoid arthritis.
    Arthritis Rheum. 2011 Nov 10. doi: 10.1002/art.33472.
    PubMed     Text format     Abstract available


  276. LINDOP R , Arentz G, Chataway TK, Thurgood LA, et al
    Molecular signature of a public clonotypic autoantibody in primary Sjogren's syndrome: A "forbidden" clone in systemic autoimmunity.
    Arthritis Rheum. 2011;63:3477-86.
    PubMed     Text format     Abstract available


    October 2011
  277. KIM KW , Kim HR, Park JY, Park JS, et al
    IL-22 promotes osteoclastogenesis in rheumatoid arthritis through induction of RANKL in human synovial fibroblasts.
    Arthritis Rheum. 2011 Oct 27. doi: 10.1002/art.33446.
    PubMed     Text format     Abstract available


  278. DWIVEDI N , Upadhyay J, Neeli I, Khan S, et al
    Felty's syndrome autoantibodies bind to deiminated histones and neutrophil extracellular traps.
    Arthritis Rheum. 2011 Oct 27. doi: 10.1002/art.33432.
    PubMed     Text format     Abstract available


  279. WANG JG , Xu WD, Zhai WT, Li Y, et al
    Disorders in angiogenesis and redox pathways are main factors contributing to the progression of rheumatoid arthritis: a comparative proteomic study.
    Arthritis Rheum. 2011 Oct 17. doi: 10.1002/art.33425.
    PubMed     Text format     Abstract available


  280. KREMER JM , Cohen S, Wilkinson BE, Connell CA, et al
    A Phase 2B dose-ranging study of the oral JAK inhibitor tofacitinib (CP-690,550) versus placebo in combination with background methotrexate in patients with active rheumatoid arthritis and inadequate response to methotrexate alone.
    Arthritis Rheum. 2011 Oct 17. doi: 10.1002/art.33419.
    PubMed     Text format     Abstract available


  281. ROSSOL M , Kraus S, Pierer M, Baerwald C, et al
    The CD14(bright) CD16+ monocyte subset is expanded in rheumatoid arthritis and promotes Th17 expansion.
    Arthritis Rheum. 2011 Oct 17. doi: 10.1002/art.33418.
    PubMed     Text format     Abstract available


  282. MIKULS TR , Levan T, Gould KA, Yu F, et al
    Interactions of cigarette smoking with NAT2 polymorphisms impact rheumatoid arthritis risk in African Americans.
    Arthritis Rheum. 2011 Oct 11. doi: 10.1002/art.33408.
    PubMed     Text format     Abstract available


  283. SUI J , Li H, Fang Y, Liu Y, et al
    NLRP1 gene polymorphism influences gene transcription and is a risk factor for rheumatoid arthritis in Han Chinese.
    Arthritis Rheum. 2011 Oct 4. doi: 10.1002/art.33370.
    PubMed     Text format     Abstract available


  284. ILIOU C , Anthis N, Tsifetaki N, Kitsos G, et al
    Corneal melt in a woman with longstanding rheumatoid arthritis.
    Arthritis Rheum. 2011 Oct 3. doi: 10.1002/art.33389.
    PubMed     Text format    


  285. DUER-JENSEN A , Horslev-Petersen K, Hetland ML, Bak L, et al
    MRI predicts development of rheumatoid arthritis in undifferentiated arthritis. Reply to comment by van der Helm-van Mil et al.
    Arthritis Rheum. 2011 Oct 3. doi: 10.1002/art.33401.
    PubMed     Text format    


  286. VAN DER HELM-VAN MIL AH , Huizinga TW, le Cessie S
    The additive value of MRI bone edema in predicting rheumatoid arthritis development in early undifferentiated arthritis. Comment on the manuscript of Duer-Jensen et al.
    Arthritis Rheum. 2011 Oct 3. doi: 10.1002/art.33397.
    PubMed     Text format    


  287. KWOK SK , Cho ML, Park MK, Oh HJ, et al
    Interleukin-21 promotes osteoclastogenesis in rheumatoid arthritis in humans and mice.
    Arthritis Rheum. 2011 Oct 3. doi: 10.1002/art.33390.
    PubMed     Text format     Abstract available


  288. COLASANTI T , Maselli A, Conti F, Sanchez M, et al
    Autoantibodies to estrogen receptor alpha interfere with T lymphocyte homeostasis and are associated with disease activity in systemic lupus erythematosus.
    Arthritis Rheum. 2011 Oct 3. doi: 10.1002/art.33400.
    PubMed     Text format     Abstract available


  289. SATO-HAYASHIZAKI A , Ohtsuji M, Lin Q, Hou R, et al
    Presumptive role of 129 strain-derived Sle16 locus in rheumatoid arthritis in a new mouse model with Fcgamma receptor type IIb-deficient C57BL/6 genetic background.
    Arthritis Rheum. 2011;63:2930-8.
    PubMed     Text format     Abstract available


  290. FELSON DT
    American College of Rheumatology hybrid measure for assessing efficacy of treatment in patients with refractory rheumatoid arthritis: Comment on the article by Genovese et al.
    Arthritis Rheum. 2011;63:3181-2.
    PubMed     Text format    


  291. LANDEWE R , Gorter S, Gaujoux-Viala C, Gossec L, et al
    On publication policy, combination therapy, and the European League Against Rheumatism recommendations for the management of rheumatoid arthritis: Comment on the article by Graudal et al.
    Arthritis Rheum. 2011;63:3182-5.
    PubMed     Text format    


  292. SNIR O , Rieck M, Gebe JA, Yue BB, et al
    Identification and functional characterization of T cells reactive to citrullinated vimentin in HLA-DRB1*0401-positive humanized mice and rheumatoid arthritis patients.
    Arthritis Rheum. 2011;63:2873-83.
    PubMed     Text format     Abstract available


    September 2011
  293. HARROLD LR , Harrington JT, Curtis JR, Furst DE, et al
    Prescribing practices in a US cohort of rheumatoid arthritis patients before and after publication of the ACR treatment recommendations.
    Arthritis Rheum. 2011 Sep 27. doi: 10.1002/art.33380.
    PubMed     Text format     Abstract available


  294. KARONITSCH T , Dalwigk K, Steiner CW, Bluml S, et al
    Interferon (IFN) signals and monocytic sensitization of the IFNgamma signaling pathway in peripheral blood of rheumatoid arthritis patients.
    Arthritis Rheum. 2011 Sep 27. doi: 10.1002/art.33347.
    PubMed     Text format     Abstract available


  295. DEN UYL D , van Raalte DH, Nurmohamed MT, Lems WF, et al
    Metabolic effects of high-dose prednisolone treatment in early rheumatoid arthritis: Diabetogenic effects and inflammation reduction on the balance.
    Arthritis Rheum. 2011 Sep 27. doi: 10.1002/art.33378.
    PubMed     Text format     Abstract available


  296. SANTIAGO B , Izquierdo E, Rueda P, Rey MJ, et al
    CXCL12gamma isoform is expressed on endothelial and dendritic cells in rheumatoid arthritis synovium and regulates T-cell activation.
    Arthritis Rheum. 2011 Sep 27. doi: 10.1002/art.33345.
    PubMed     Text format     Abstract available


  297. PRAHALAD S , Thompson SD, Conneely KN, Jiang Y, et al
    Hierarchy of risk of childhood onset rheumatoid arthritis conferred by HLA-DRB1 alleles encoding the shared epitope.
    Arthritis Rheum. 2011 Sep 27. doi: 10.1002/art.33376.
    PubMed     Text format     Abstract available


  298. MORET FM , Badot V, Lauwerys BR, van Roon JA, et al
    Characterization of IL-7 and IL-7R in the pathogenesis of rheumatoid arthritis: Comment on the article by Pickens et al.
    Arthritis Rheum. 2011 Sep 27. doi: 10.1002/art.33373.
    PubMed     Text format    


  299. CHAN WF , Atkins CJ, Naysmith D, van der Westhuizen N, et al
    Microchimerism in the rheumatoid nodules of rheumatoid arthritis patients.
    Arthritis Rheum. 2011 Sep 27. doi: 10.1002/art.33358.
    PubMed     Text format     Abstract available


  300. FLEISCHMANN R , Cutolo M, Genovese MC, Lee EB, et al
    Phase 2B dose-ranging study of the oral JAK inhibitor tofacitinib (CP-690,550) or adalimumab monotherapy versus placebo in patients with active rheumatoid arthritis with an inadequate response to DMARDs.
    Arthritis Rheum. 2011 Sep 27. doi: 10.1002/art.33383.
    PubMed     Text format     Abstract available


  301. GILLESPIE J , Savic S, Wong C, Hempshall A, et al
    Histone deacetylases are dysregulated in rheumatoid arthritis and a novel HDAC3-selective inhibitor reduces IL-6 production by PBMC of RA patients.
    Arthritis Rheum. 2011 Sep 27. doi: 10.1002/art.33382.
    PubMed     Text format     Abstract available


  302. PLANT D , Prajapati R, Hyrich KL, Morgan AW, et al
    Investigation of established rheumatoid-arthritis (RA) susceptibility genetic markers as predictors of response to anti-TNF therapy in a large UK cohort replicates association with the PTPRC gene.
    Arthritis Rheum. 2011 Sep 27. doi: 10.1002/art.33381.
    PubMed     Text format     Abstract available


  303. FALK M , Christian B, Axel S, Hans-Jorg W, et al
    Molecular imaging of cartilage damage of finger joints in early rheumatoid arthritis with delayed Gd(DTPA)2- enhanced MRI.
    Arthritis Rheum. 2011 Sep 27. doi: 10.1002/art.33352.
    PubMed     Text format     Abstract available


  304. KONDO Y , Iizuka M, Wakamatsu E, Yao Z, et al
    Overexpression of T-bet gene regulates murine autoimmune arthritis.
    Arthritis Rheum. 2011 Sep 8. doi: 10.1002/art.33335.
    PubMed     Text format     Abstract available


  305. KOIKE T
    IFNgamma independent suppression of Th-17 differentiation by T-bet expression in autoimmune arthritis mice.
    Arthritis Rheum. 2011 Sep 8. doi: 10.1002/art.33331.
    PubMed     Text format    


  306. DE BEECK KO , Maes L, Van den Bergh K, Derua R, et al
    Heterogeneous nuclear ribonucleoproteins as targets of autoantibodies in systemic rheumatic diseases.
    Arthritis Rheum. 2011 Sep 8. doi: 10.1002/art.33327.
    PubMed     Text format     Abstract available


  307. NORDAL E , Songstad NT, Rygg M
    Difficulties in defining antinuclear antibody-positive patients as a separate category in the classification of juvenile idiopathic arthritis: Comment on the article by Ravelli et al.
    Arthritis Rheum. 2011;63:2835.
    PubMed     Text format    


  308. SHIBATA-NOZAKI T , Ito H, Mitomi H, Akaogi J, et al
    Endogenous prostaglandin E2 inhibits aberrant overgrowth of rheumatoid synovial tissue and the development of osteoclast activity through EP4 receptor.
    Arthritis Rheum. 2011;63:2595-605.
    PubMed     Text format     Abstract available


  309. SPURLOCK CF 3RD , Aune ZT, Tossberg JT, Collins PL, et al
    Increased sensitivity to apoptosis induced by methotrexate is mediated by JNK.
    Arthritis Rheum. 2011;63:2606-16.
    PubMed     Text format     Abstract available


  310. KUKITA A , Kukita T, Nagata K, Teramachi J, et al
    The transcription factor FBI-1/OCZF/LRF is expressed in osteoclasts and regulates RANKL-induced osteoclast formation in vitro and in vivo.
    Arthritis Rheum. 2011;63:2744-54.
    PubMed     Text format     Abstract available


  311. LOPES F , Coelho FM, Costa VV, Vieira EL, et al
    Resolution of neutrophilic inflammation by H2O2 in antigen-induced arthritis.
    Arthritis Rheum. 2011;63:2651-60.
    PubMed     Text format     Abstract available


  312. JONES NR , Pegues MA, McCrory MA, Kerr SW, et al
    Collagen-induced arthritis is exacerbated in C-reactive protein-deficient mice.
    Arthritis Rheum. 2011;63:2641-50.
    PubMed     Text format     Abstract available


  313. NORDAL E , Zak M, Aalto K, Berntson L, et al
    Ongoing disease activity and changing categories in a long-term nordic cohort study of juvenile idiopathic arthritis.
    Arthritis Rheum. 2011;63:2809-18.
    PubMed     Text format     Abstract available


  314. JOHNSEN AK , Valdar W, Golden L, Ortiz-Lopez A, et al
    Genome-wide and species-wide dissection of the genetics of arthritis severity in heterogeneous stock mice.
    Arthritis Rheum. 2011;63:2630-40.
    PubMed     Text format     Abstract available


    August 2011
  315. FREED BM , Schuyler RP, Aubrey MT
    HLA-DRB1 epitope LA(67,74) is associated with rheumatoid arthritis and citrullinated vimentin binding.
    Arthritis Rheum. 2011 Aug 26. doi: 10.1002/art.30636.
    PubMed     Text format     Abstract available


  316. GILES JT , Post WS, Blumenthal RS, Polak J, et al
    Longitudinal predictors of progression of carotid atherosclerosis in rheumatoid arthritis.
    Arthritis Rheum. 2011 Aug 16. doi: 10.1002/art.30542.
    PubMed     Text format     Abstract available


  317. YAZICI H , Tascilar K, Kiroglu G, Erar A, et al
    Mortality bias in reporting cancer incidence in disease registries: comment on the article by Chen et al.
    Arthritis Rheum. 2011;63:2543-4.
    PubMed     Text format    


  318. BINIECKA M , Fox E, Gao W, Ng CT, et al
    Hypoxia induces mitochondrial mutagenesis and dysfunction in inflammatory arthritis.
    Arthritis Rheum. 2011;63:2172-82.
    PubMed     Text format     Abstract available


  319. CURTIS JR , Chen L, Luijtens K, Navarro-Millan I, et al
    Dose escalation of certolizumab pegol from 200 mg to 400 mg every other week provides no additional efficacy in rheumatoid arthritis: an analysis of individual patient-level data.
    Arthritis Rheum. 2011;63:2203-8.
    PubMed     Text format     Abstract available


  320. COSMI L , Cimaz R, Maggi L, Santarlasci V, et al
    Evidence of the transient nature of the Th17 phenotype of CD4+CD161+ T cells in the synovial fluid of patients with juvenile idiopathic arthritis.
    Arthritis Rheum. 2011;63:2504-15.
    PubMed     Text format     Abstract available


  321. MIOSSEC P
    Interleukin-17 and Th17 cells: from adult to juvenile arthritis--now it is serious!
    Arthritis Rheum. 2011;63:2168-71.
    PubMed     Text format    


    July 2011
  322. WALDBURGER JM , Palmer G, Seemayer C, Lamacchia C, et al
    Autoimmunity and inflammation are independent of CIITA pIV dependent MHCII expression in peripheral tissues during collagen induced arthritis.
    Arthritis Rheum. 2011 Jul 7. doi: 10.1002/art.30522.
    PubMed     Text format     Abstract available


    June 2011
  323. YOSHIDA K , Komai K, Shiozawa K, Mashida A, et al
    Role of MICA polymorphism in systemic lupus erythematosus.
    Arthritis Rheum. 2011 Jun 23. doi: 10.1002/art.30501.
    PubMed     Text format     Abstract available


    April 2011
  324. MORIMOTO AM , Flesher DT, Yang J, Wolslegel K, et al
    Association of endogenous anti-interferon-alpha autoantibodies with decreased interferon-pathway and disease activity in patients with systemic lupus erythematosus.
    Arthritis Rheum. 2011 Apr 19. doi: 10.1002/art.30399.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Rheumatoid Arthritis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: